People with cancer under chemotherapy. Malignant neoplasm, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age greater than 18 and less than 70 years Cancer patients with at least one chemotherapy course with a 21 day interval from the last session. Detect stage 2, 3, and 4 of all cancers other than head and neck and lung with the opinion of the relevant physician. Full vigilance No history of cigarette and drug addiction Earning a score higher than 20 after responding to the Spielberger questionnaire in the pre-test Non-use of benzodiazepines, tranquillizers and opioids during intervention Without a history of migraine and chronic headaches Non-impaired sense of smell (without obstruction and nasal congestion) and healthy sense of smell) through smelling of alcohol). Inability of the patient to answer questions (in terms of physical and mental status) lack of patient psychiatric problems (hospitalization or other medical treatment is not due to mental disorders). Stable and stable hemodynamic status Not having a history of allergy to the smell of herbs and any scent or fragrance Not having respiratory diseases The desire to participate in research Do not use any other scent during the study
Exclusion criteria
Exclusion criteria: Patients with head and neck cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue of patients with cancer under chemotherapy. Timepoint: Before the intervention and 30, 60 minutes after the intervention for three consecutive days. Method of measurement: Standard Fatigue Fatigue Questionnaire (BFI).;Anxiety in patients with cancer under chemotherapy. Timepoint: Before the intervention and 20 minutes after the intervention for three consecutive days. Method of measurement: Spilberger Situational Anxiety Inventory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Arak University of Medical Sciences